(Date:11/21/2009)...vember 20,2009 / b3c newswire / - KINAXO Biotech...cing round, gaining two new investors in the compa...NAXO reports that Jrgen Schumacher has been electe..., KINAXO shareholders Axel Ullrich, Hellmut Kirc...tutional investors Mountain Partners, BioM, High-T...
(Date:11/20/2009)...ve all read studies about the health benefits of h...e molecular level, where amino acids known as cyst...le than when paired up with other cysteines. , N...ng with colleagues in Belgium, have discovered a n...es. The research appears in the Nov. 20 issue of t...
(Date:11/20/2009)...d to contribute their abstracts to the World Congr...argest global meeting devoted to all aspects of os... care. The Congress will be held in Florence, Ital...ts can be submitted online at http://www.iofwco-e...ry 4, 2010. , IOF and ESCEO are pleased to annou...
Breaking Biology News(10 mins):KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3Saving the single cysteine: New antioxidant system found 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3Drug rescues memory lost to Alzheimers disease 51674 1Drug rescues memory lost to Alzheimers disease 51674 2Sono Tek Announces First Quarter Results 51672 1Sono Tek Announces First Quarter Results 51672 2Sono Tek Announces First Quarter Results 51672 3Leading Senior Care Destination TheCaringSpace com Launches ElderCare Library and Care Community 51670 1Leading Senior Care Destination TheCaringSpace com Launches ElderCare Library and Care Community 51670 2(Date:11/19/2009)...EAL, Nov. 19 /PRNewswire/ - Aegera Therapeutics In... in a randomized Phase 2B study of AEG35156, a tar...nt for multiple oncology indications. ,, The st...udy of the X-Linked Inhibitor of Apoptosis (XIAP) ...dose Cytarabine and Idarubicin in AML Following Fa...
(Date:11/19/2009)... VIENNA, Austria, November 19 AF...m on one product candidate at an unexpectedly earl... is planned to enter into,Phase II clinical trial ...ately follows the completion of two Phase I trials...sed its fast decision on the first interim,analysi...
(Date:11/18/2009)...ll. Imagine a polka-dotted postage stamp that can... by changing colors. , As reported in the Sept. ...h Suslick and his team at the University of Illino...al detection of toxic industrial chemicals (TICs) ... visualizing odors. This sensor array could be us...
(Date:11/18/2009)...E, Calif., Nov. 18 Mas...metry(TM) and Measure-Through Motion and Low-Perfu...ance-based Uni.H.A., one of the largest healthcare...as signed a multi-year purchasing agreement for "g... The agreement offers preferred contract pricing t...
Breaking Biology Technology:Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4A research group based at the University of Chicago has found that an enriched environment -- in this case more chances to exercise, explore and interact with others can dramatically reduce the biolo
...an Chemical Society (ACS) has strongly backed a gr...10, which will improve federal coordination, disse...h and development......."Green chemistry technolog...ed industry money," according to ACS President Wil...
NOTE: Due to an embargo break, the embargo on this release has been lifted.......Anthropologists have constructed the world's first complete articulated Neanderthal skeleton to expand public and scien
....Y. -- Oral biologists at the University at Buffal...naturally occurring antifungal agent in saliva, ki... responsible for most HIV-related oral infections....., discovered that histatin binds to a specific me...
Enriched environment delays onset of Alzheimer's in mice 2Enriched environment delays onset of Alzheimer's in mice 3World's largest scientific society backs green chemistry bill 2Neanderthal reconstructed 2Discovery may lead to better Candidiasis drug 2.All divers risk decompression sickness if they surface too quickly for their.bodies to lose the excess gas absorbed from breathing mixtures used during the.dive. ONR-funded researchers at the Naval M
. PITTSBURGH, June 3 -- On June 1, 1999, a 50-year-old man with hemophilia.A received the first in vivo gene therapy for this disease as part of a phase I.clinical trial performed at the Univer
.Embargoed for Release until 4 p.m. on Wednesday, June 2, 1999.Genetic Testing and Modified Diets May Save Babies Born With Genetic Defect,.Wake Forest University Baptist Medical Center Study Shows.WI
...atic improvement in imaging techniques it is now p...e monkey brain in a quality never seen.before. A r... Logothetis of the.Max Planck Institute for Biolog...genberger of the Eberhard Karl University (both in...
University of Pittsburgh Medical Center performs first in vivo gene therapy for hemophilia A 2University of Pittsburgh Medical Center performs first in vivo gene therapy for hemophilia A 3Genetic testing and modified diets may save babies born with genetic defect 2Genetic testing and modified diets may save babies born with genetic defect 3A sharper look at the brain 2A sharper look at the brain 3